May 10 – May 28, 2019
The purpose of this bulletin is to compile a handful of articles relating to health care coverage in the United States that are most pertinent to LIUNA and its health and welfare funds. We hope you find this biweekly bulletin helpful and informative.
More than 2 million people in the U.S. work in or near agriculture fields that are treated with pesticides.
The Trump administration is arguing in court that the entire Affordable Care Act should be struck down as unconstitutional. But at the same time, Justice Department lawyers recently suggested that federal judges could salvage its anti-fraud provisions, raising questions about keeping other parts as well.
Leading drug companies including Teva, Pfizer, Novartis and Mylan conspired to inflate the prices of generic drugs by as much as 1,000 percent, according to a far-reaching lawsuit filed on Friday by 44 states.
The Democratic and Republican leaders of the House Energy and Commerce Committee on Tuesday released a discussion draft of a measure to protect patients from getting massive, unexpected medical bills, a sign of bipartisan momentum on the issue.
Patients' risk of dying from medical mistakes, deadly infections and safety lapses have gotten much worse at the lowest ranked U.S. hospitals, underscoring Americans' need to check ratings of their local hospitals, new research released Wednesday shows.
For the first time, the federal government is shining a spotlight on the quality of rehabilitation care at nursing homes — services used by nearly 2 million older adults each year.
State officials in Texas and Louisiana have launched multiple probes into the Cenikor Foundation following an investigation by Reveal that found the prominent drug rehab has turned patients into an unpaid labor force for private companies.
Losing such a key executive so early in the process could be a big setback for Haven, which has laid out an ambitious effort to bring down health-care costs, starting with the combined 1.2 million employees at the three companies.
The federal Food and Drug Administration has approved a gene therapy for a rare childhood disorder that is now the most expensive drug on the market. It costs $2.125 million per patient.
STATES IN THE NEWS
Starting in October, you’ll need to be 21 to buy tobacco and nicotine products in Maryland, under a bill that Gov. Larry Hogan plans to sign into law on Monday.
Gov. Jay Inslee on Monday signed into law a bill that creates a public option for Washington’s health benefit exchange, a move intended to lower costs and boost insurance coverage across the state.
There were 15,246 suicides deaths in Ohio over that 10-year span, for an average annual rate of 13.3 deaths per 100,000 people.
The closure of a local hospital is a very real possibility for the people of Greeneville, a hardscrabble Appalachian community of 15,000 about an hour east of Knoxville.
She's part of Minnesota's small cadre of certified community paramedics, who visit patients at home to help them with transitions out of the hospital and with managing chronic conditions.
More Americans are diagnosed with skin cancer annually than all other cancers combined, and one in five will develop skin cancer by the age of 70, according to the American Cancer Society.
Diabetics in Colorado who use insulin to control their blood sugar levels won’t pay more than $100 per month for the drug starting in January thanks to a bill signed into law by Gov. Jared Polis on Wednesday.